Annual Total Assets
$8.80 M
-$19.25 M-68.61%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual total assets is $8.80 million, with the most recent change of -$19.25 million (-68.61%) on December 31, 2023.
- During the last 3 years, CYCC annual total assets has fallen by -$28.00 million (-76.07%).
- CYCC annual total assets is now -88.40% below its all-time high of $75.91 million, reached on December 31, 2007.
Performance
CYCC Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$5.38 M
-$2.81 M-34.30%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly total assets is $5.38 million, with the most recent change of -$2.81 million (-34.30%) on September 30, 2024.
- Over the past year, CYCC quarterly total assets has dropped by -$3.42 million (-38.89%).
- CYCC quarterly total assets is now -94.04% below its all-time high of $90.25 million, reached on March 31, 2007.
Performance
CYCC Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
CYCC Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.6% | -38.9% |
| 3 y3 years | -76.1% | -75.6% |
| 5 y5 years | -55.6% | -75.6% |
CYCC Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.6% | at low | -87.5% | at low |
| 5 y | 5-year | -79.6% | at low | -89.6% | at low |
| alltime | all time | -88.4% | at low | -94.0% | at low |
Cyclacel Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.38 M(-34.3%) |
| Jun 2024 | - | $8.19 M(+32.8%) |
| Mar 2024 | - | $6.17 M(-30.0%) |
| Dec 2023 | $8.80 M(-68.6%) | $8.80 M(-29.5%) |
| Sep 2023 | - | $12.50 M(-24.0%) |
| Jun 2023 | - | $16.44 M(-25.5%) |
| Mar 2023 | - | $22.06 M(-21.4%) |
| Dec 2022 | $28.05 M(-35.0%) | $28.05 M(-9.6%) |
| Sep 2022 | - | $31.02 M(-12.2%) |
| Jun 2022 | - | $35.35 M(-10.8%) |
| Mar 2022 | - | $39.63 M(-8.1%) |
| Dec 2021 | $43.14 M(+17.2%) | $43.14 M(-4.1%) |
| Sep 2021 | - | $45.00 M(-2.9%) |
| Jun 2021 | - | $46.33 M(-10.6%) |
| Mar 2021 | - | $51.82 M(+40.8%) |
| Dec 2020 | $36.80 M(+140.4%) | $36.80 M(+35.2%) |
| Sep 2020 | - | $27.21 M(-6.7%) |
| Jun 2020 | - | $29.17 M(+124.6%) |
| Mar 2020 | - | $12.99 M(-15.2%) |
| Dec 2019 | $15.31 M(-22.8%) | $15.31 M(-10.4%) |
| Sep 2019 | - | $17.08 M(-12.3%) |
| Jun 2019 | - | $19.46 M(-9.5%) |
| Mar 2019 | - | $21.51 M(+8.5%) |
| Dec 2018 | $19.82 M(-23.8%) | $19.82 M(-4.3%) |
| Sep 2018 | - | $20.71 M(-8.9%) |
| Jun 2018 | - | $22.73 M(-8.3%) |
| Mar 2018 | - | $24.78 M(-4.7%) |
| Dec 2017 | $26.00 M(+32.3%) | $26.00 M(-6.6%) |
| Sep 2017 | - | $27.85 M(+73.2%) |
| Jun 2017 | - | $16.08 M(-5.8%) |
| Mar 2017 | - | $17.07 M(-13.2%) |
| Dec 2016 | $19.66 M(-20.6%) | $19.66 M(-13.2%) |
| Sep 2016 | - | $22.65 M(+20.0%) |
| Jun 2016 | - | $18.88 M(-12.0%) |
| Mar 2016 | - | $21.46 M(-13.3%) |
| Dec 2015 | $24.76 M(-15.7%) | $24.76 M(-8.4%) |
| Sep 2015 | - | $27.05 M(-12.1%) |
| Jun 2015 | - | $30.79 M(-12.9%) |
| Mar 2015 | - | $35.36 M(+20.3%) |
| Dec 2014 | $29.39 M(-17.3%) | $29.39 M(-7.1%) |
| Sep 2014 | - | $31.63 M(-15.9%) |
| Jun 2014 | - | $37.61 M(+11.3%) |
| Mar 2014 | - | $33.78 M(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $35.52 M(+83.5%) | $35.52 M(-6.5%) |
| Sep 2013 | - | $37.99 M(+1.3%) |
| Jun 2013 | - | $37.51 M(+114.5%) |
| Mar 2013 | - | $17.49 M(-9.7%) |
| Dec 2012 | $19.35 M(-25.6%) | $19.35 M(-5.7%) |
| Sep 2012 | - | $20.53 M(-5.9%) |
| Jun 2012 | - | $21.80 M(-14.0%) |
| Mar 2012 | - | $25.34 M(-2.5%) |
| Dec 2011 | $26.00 M(-17.4%) | $26.00 M(-10.2%) |
| Sep 2011 | - | $28.95 M(+27.5%) |
| Jun 2011 | - | $22.70 M(-16.6%) |
| Mar 2011 | - | $27.20 M(-13.5%) |
| Dec 2010 | $31.46 M(+117.5%) | $31.46 M(+54.3%) |
| Sep 2010 | - | $20.39 M(-8.6%) |
| Jun 2010 | - | $22.31 M(-16.7%) |
| Mar 2010 | - | $26.78 M(+85.1%) |
| Dec 2009 | $14.47 M(-53.3%) | $14.47 M(-17.5%) |
| Sep 2009 | - | $17.54 M(-9.9%) |
| Jun 2009 | - | $19.46 M(-22.7%) |
| Mar 2009 | - | $25.17 M(-18.7%) |
| Dec 2008 | $30.96 M(-59.2%) | $30.96 M(-25.6%) |
| Sep 2008 | - | $41.63 M(-27.3%) |
| Jun 2008 | - | $57.22 M(-13.5%) |
| Mar 2008 | - | $66.12 M(-12.9%) |
| Dec 2007 | $75.91 M(+20.0%) | $75.91 M(-5.6%) |
| Sep 2007 | - | $80.44 M(-6.0%) |
| Jun 2007 | - | $85.54 M(-5.2%) |
| Mar 2007 | - | $90.25 M(+42.6%) |
| Dec 2006 | $63.28 M(+231.8%) | $63.28 M(-6.3%) |
| Sep 2006 | - | $67.52 M(-7.1%) |
| Jun 2006 | - | $72.67 M(+90.5%) |
| Mar 2006 | - | $38.14 M(+100.0%) |
| Dec 2005 | $19.07 M(-65.7%) | $19.07 M(-36.8%) |
| Sep 2005 | - | $30.20 M(-26.9%) |
| Jun 2005 | - | $41.31 M(-15.0%) |
| Mar 2005 | - | $48.58 M(-12.6%) |
| Dec 2004 | $55.60 M(+200.6%) | $55.60 M(+58.8%) |
| Sep 2004 | - | $35.01 M(-12.2%) |
| Jun 2004 | - | $39.86 M(-11.4%) |
| Mar 2004 | - | $45.01 M(+143.3%) |
| Dec 2003 | $18.50 M(-14.1%) | $18.50 M |
| Dec 2002 | $21.54 M(-12.9%) | - |
| Dec 2001 | $24.73 M(-13.2%) | - |
| Dec 2000 | $28.48 M | - |
FAQ
- What is Cyclacel Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual total assets year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly total assets year-on-year change?
What is Cyclacel Pharmaceuticals annual total assets?
The current annual total assets of CYCC is $8.80 M
What is the all time high annual total assets for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual total assets is $75.91 M
What is Cyclacel Pharmaceuticals annual total assets year-on-year change?
Over the past year, CYCC annual total assets has changed by -$19.25 M (-68.61%)
What is Cyclacel Pharmaceuticals quarterly total assets?
The current quarterly total assets of CYCC is $5.38 M
What is the all time high quarterly total assets for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly total assets is $90.25 M
What is Cyclacel Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, CYCC quarterly total assets has changed by -$3.42 M (-38.89%)